Jump to top menu Jump to main menu Jump to content

News, stories and events (170)

New discovery: DNA protects itself in loops under stress

New discovery: DNA protects itself in loops under stress

Nitika Taneja shows how cells can protect newly copied DNA when the copying process is under stress: it protects itself by stabilizing into loops. This protective organization may also help explain how tumor cells tolerate stress caused by chemotherapy. ‘When DNA is under stress, it doesn’t just get repaired, it hides inside protective loops.’

Read more
Nitika investigates why some cancer cells are resistant to chemotherapy

Nitika investigates why some cancer cells are resistant to chemotherapy

Nitika Taneja is working on a technique to better visualize the DNA of tumor cells. Through this work, she hopes to contribute to improved treatment options from the laboratory for people with cancer. ‘Sometimes half of the patients do not respond to a treatment.’

Read more
Roof Passage

Erasmus MC is investing in the healthcare of tomorrow

Annual report 2025

Read more
Organoids accelerate the search for antiviral drugs

Organoids accelerate the search for antiviral drugs

Finding drugs for outbreaks of new virusses often takes a lot of time. Researchers at Erasmus MC now show that this process can be sped up using organoids: miniature versions of human organs. Thanks to new techniques, these can now be used to expeditiously identify antiviral drugs. 

Read more

Cyberincident-bij-leverancier-ChipSoft

Read more
Researchers shed light on vascular ageing

Researchers shed light on vascular ageing

Researchers at Erasmus MC are gaining an increasingly clear understanding of vascular ageing. Two PhD theses from the research group of Ingrid van der Pluijm show that DNA damage plays a major role and that the ageing process is not necessarily irreversible. ‘Man is as old as his arteries.’

Read more
Repeated blood tests predict heart failure risk, especially in women

Repeated blood tests predict heart failure risk, especially in women

Repeated measurements of the blood marker NT-proBNP, a hormone fragment indicating heart strain, can accurately predict the risk of heart failure, particularly in women. Researchers from Erasmus MC published their findings in the scientific journal Mayo Clinic Proceedings.

Read more

Science journalist receives ERC FRONTIERS grant to investigate how research at Erasmus MC addresses the women’s health gap

In 2024, the World Economic Forum estimated that women spend 25% more of their lives in poor health than men. At the heart of women’s health gap lies a long-standing assumption in biomedical science: the male body as the default model of human biology.

Read more
DNA test: who benefits from chemotherapy for ovarian cancer?

DNA test: who benefits from chemotherapy for ovarian cancer?

Why does chemotherapy work for some patients and not for others? Researchers at Erasmus MC have found a promising clue in the dividing DNA of cancer cells. They hope this will enable them to predict which women with ovarian cancer will truly benefit from chemotherapy.

Read more
Illness in older age is not a given: insights from 35 years of Rotterdam population research

Illness in older age is not a given: insights from 35 years of Rotterdam population research

The longest-running population study in the Netherlands – The Rotterdam Study – in the Ommoord district is 35 years old. Professor of Epidemiology and research leader Arfan Ikram is still enthusiastic. The insights from ERGO have led to policy changes in the Netherlands and beyond. ‘It has triggered a change in thinking.’

Read more
AI detects DNA switches, assists in diagnosing rare genetic disorders

AI detects DNA switches, assists in diagnosing rare genetic disorders

Researchers at Erasmus MC are utilizing artificial intelligence to search for hidden switches in DNA. This approach may enable individuals with rare genetic disorders to receive a diagnosis. ‘A diagnosis is the first step towards a potential treatment.’

Read more
World’s first database for advanced cutaneous squamous cell carcinoma

World’s first database for advanced cutaneous squamous cell carcinoma

Researchers at the Erasmus MC Cancer Institute have developed a nationwide database containing a wealth of information on cutaneous squamous cell carcinoma (CSCC). This resource will soon enable doctors to provide more personalized treatments for patients with this type of skin cancer.

Read more